Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2010 Sep–Oct;19(5):404–409. doi: 10.1016/j.jstrokecerebrovasdis.2009.08.003

Table 1.

Inputs for the cost-utility model. Please see the supplemental material for additional reference material.

Variables CAS CEA Range Distribution
base base
case case
Beginning as well (vs. minor stroke, %) 46 46 0–1 Beta
Transition rates (%):
Death after a major stroke (case-fatality
rate)
13.9 13.9 10.5–17.4 Beta
30-day
  Death 0.62 1.26 0–5.1 Beta
  Minor stroke 3.81 2.66 0–12.8 Beta
  Major stroke 3.21 2.02 0–7.3 Beta
  MI 0.64 1.31 0–12.8 Beta
Long-term
  Death, excess, per year 1.5 0.96 0–44.6 Beta
  Any stroke, per year 4.0 2.1 0–18 Beta
    Proportion major stroke 0.3 0.3 0–0.75 Beta
Costs (2007$):
Hospitalization cost for MI 9,100 9,100 5,000–
15,000
Triangular
  minor stroke 9,800 9,800 5,000–
15,000
Triangular
  major stroke 10,500 10,500 5,000–
15,000
Triangular
15,000
Continuing (per yr) - MI 4,500 4,500 3,500–5,500 Triangular
  minor stroke 7,500 7,500 1,000–
15,000
Triangular
  major stroke – first year 66,500 66,500 40–90,000 Triangular
  major stroke – subsequent years 33,900 33,900 15–55,000 Triangular
Procedure 10,400 9,170 6,000–
15,000
Triangular
Clopidogrel 130
Utilities:
Myocardial infarction 0.88 0.88 0.65–1.0 Uniform
Minor stroke 0.65 0.65 0.5–0.9 Uniform
Major stroke 0.15 0.15 0–0.5 Uniform